SCHEMBL24765254

SCHEMBL24765254

CCn1c(=O)[nH]c2cnc(N)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.48
PDE4A P27815 5/20 0.48
PDE4B Q07343 5/20 0.48
PDE4C Q08493 5/20 0.48
PDE4D Q08499 5/20 0.48
CYP1A2 P05177 3/20 0.43
ADORA3 P0DMS8 2/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP1 O94782 5/20 0.40
BLM P54132 2/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
PMP22 Q01453 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30110671 0.80 ADORA3 (0.62) ADORA2AADORA3USP1CYP3A4SMN1; SMN2
SCHEMBL12639129 0.79 PDE4A (0.42) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL30110559 0.76 MTOR (0.55) CYP1A2ADORA3MEN1KMT2AUSP1
SCHEMBL23392983 0.76 MTOR (0.55) CYP1A2ADORA3MEN1KMT2AUSP1
SCHEMBL7215331 0.76 ADORA3 (0.68) CYP1A2ADORA3MEN1KMT2AUSP1
SCHEMBL1265157 0.76 JAK2 (0.58) ADORA2AADORA3USP1ADORA1
SCHEMBL28671352 0.74 PDE4A (0.46) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL8405232 0.71 ADORA2A (0.46) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL21285531 0.71 CYP1A2 (0.49) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL10370575 0.70 EEF2K (0.52) ADORA2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022262784-A1 IDH MUTANT INHIBITOR AND USE THEREOF 微境生物医药科技(上海)有限公司 2022-12-22 WO disclosed